Australian biopharmaceuticals developer Cynata Therapeutics (ASX: CYP) has returned highly encouraging data from its preclinical trials for its Cymerus™ product aiming to treat sepsis, the most common cause of death in hospital intensive care units. Sepsis, a form of blood poisoning, continues to be a major health problem in hospitals which accounts for 50% of
Read More
Having been in a voluntary trading halt since last trading on 3 April 2019, shareholders of Sky and Space Global (ASX: SAS) may finally have some closure with signs now pointing to the Israeli-based space company being put into administration. Earlier in the year, we brought attention to the series of capital raises undertaken by
Read More
Confirming their commitment announced in April 2019, the Morrison Government has signed a $5 million grant to Australian medtech company PainChek (ASX: PCK) which will provide dementia patients with licences to utilise the facial recognition software for the purpose of assessing pain. Key to the software which has been clinically tested is its ability to
Read More
Australian biopharmaceuticals developer Neuren Pharmaceuticals (ASX: NEU) has been granted a patent from the European Patent Office covering NNZ-2591, a world-first drug being developed to treat three neurodevelopmental disorders which affect children, and are currently incurable. The granting of the new patent is the third jurisdiction to do so for Neuren with the same application
Read More
Telecommunications provider amaysim (ASX: AYS) has strengthened its recurring mobile subscriber base through the acquisition of Jeenee Communications and its 41,700 subscribers. The purchase of the privately-held mobile virtual network operator (MVNO) for total consideration of $7.8 million will take amaysim’s total recurring mobile subscriber base to 698,600 total users with Jeenee customers to be
Read More
Australian tech manufacturer Quantify Technology (ASX: QFY) has secured an order in excess of $500,000 for their qDevices which will be installed in three apartment buildings, converting them into SmartHomes where lighting and sound will be adjustable by occupants via voice, app and touch. The Heads of Agreement (HoA) is with Sydney based building developer
Read More
In an offer too good to refuse, owners of privately-held veterinary company Grampians Animal Health have sold the business to Apiam Animal Health (ASX: AHX) for $4.65m. Located in Hamilton, Victoria – the heartland of Victorian sheep farming – the purchase will see Apiam acquire the animal veterinary clinic as well as Livestock Logic, a
Read More
Australian video tech company Linius (ASX: LNU) has secured Australia’s National Basketball League (NBL) to its growing list of sports clients utilising their personalised video service – Video Virtualization Engine™ (VVE). As the world’s first service which transforms static video into personalised video experiences, individual users of the VVE technology will be able to individually
Read More
Australian-Singapore wastewater treatment company De.mem (ASX: DEM) has strengthened its bottom line having today announced a new contract acquisition from Swiss cosmetics and fragrances manufacturer Givaudan (SWX: GVN), valued at a minimum of $1.7m. The contract will see De.mem operate a wastewater treatment system at the Swiss conglomerate’s Singapore production facility, treating wastewater to meet
Read More
Australian beauty product manufacturer Wellness and Beauty Solutions (ASX: WNB) has secured a partnership with Sisterhood Beauty for mass distribution of their TANNED product range across 600 retail outlets in New Zealand. Launched in June 2019, the TANNED product line is a safe sunless tanning product which is currently available in Australia via Sportsgirl retail
Read More
